United Kingdom Continuous Glucose Monitoring Market Size (2024 - 2029)

The United Kingdom Continuous Glucose Monitoring market is poised for significant growth, driven by advancements in technology and the increasing demand for effective diabetes management solutions. The COVID-19 pandemic has accelerated the adoption of remote care and virtual consultations, highlighting the importance of continuous glucose monitoring in managing diabetes, particularly for insulin users. The development of new CGM models has addressed previous technical challenges, enhancing the ability of both patients and providers to monitor and manage blood glucose levels effectively. This evolution in diabetes care is expected to expand the market's scope and potential over the forecast period.

Home Market Analysis Healthcare Research Medical Devices Research United Kingdom Continuous Glucose Monitoring Market Market Size

Market Size of United Kingdom Continuous Glucose Monitoring Industry

United Kingdom Continuous Glucose Monitoring Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2018 - 2022
CAGR 15.90 %

Major Players

United Kingdom Continuous Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

United Kingdom Continuous Glucose Monitoring Market Analysis

The United Kingdom Continuous Glucose Monitoring Market is expected to register a CAGR of about 15.9% and reach a value of about USD 580 million over the forecast period.

According to The British Diabetic Association, the COVID-19 pandemic continued to have a huge impact on society. However, research and data showed that people with diabetes were disproportionately affected by COVID-19, particularly in terms of poorer outcomes when contracting the virus; that's why preventing or delaying cases of diabetes was more important than ever. The pandemic also highlighted opportunities for continuing and expanding innovations in the delivery of diabetes care through virtual consultations between healthcare providers and people with diabetes and diabetes technology. Crisis management has created unprecedented interest in remote care from both patients and providers.

Continuous Glucose Monitoring tests glucose concentration in the blood (glycemia). Particularly important in diabetes management, a blood glucose test is typically performed to determine the fluctuation in blood glucose level to take or alter the medication accordingly, especially for insulin users. Achieving optimum glycemic results can be very difficult without frequent monitoring of blood glucose levels.

Furthermore, the current continuous glucose Monitoring can either retrospectively display the trends in blood glucose levels by downloading the data or give a real-time picture of glucose levels through receiver displays. The newest CGM models, the Abbott Freestyle Libre 3 and the Dexcom G7, overcame many technical barriers. Technological advances such as Eversense E3 CGMs have significantly improved the ability of providers and patients to manage diabetes, thereby enhancing the market prospects in the years to come.

United Kingdom Continuous Glucose Monitoring Industry Segmentation

Achieving optimum glycemic results can be very difficult without frequent monitoring of blood glucose levels. A continuous glucose monitor tracks blood sugar levels 24 hours a day. It collects readings automatically every five to 15 minutes and detects trends and patterns to provide a complete picture of diabetes. The United Kingdom Continuous Glucose Monitoring Market is segmented into Component (Sensors and Durables). The report offers the value (USD) and volume (Units) for the above segments.

Component
Sensors
Durables
Need A Different Region Or Segment?
Customize Now

United Kingdom Continuous Glucose Monitoring Market Size Summary

The United Kingdom Continuous Glucose Monitoring (CGM) market is poised for significant growth, driven by the increasing prevalence of diabetes and the rising demand for advanced diabetes management solutions. The market is characterized by the adoption of innovative technologies that enhance the monitoring and management of blood glucose levels, crucial for individuals with diabetes. The COVID-19 pandemic has further accelerated the interest in remote and virtual diabetes care, highlighting the importance of continuous monitoring systems. These systems, such as the Abbott Freestyle Libre 3 and Dexcom G7, offer real-time glucose level tracking and have overcome previous technical challenges, thereby improving diabetes management outcomes. The integration of CGM with insulin calculators and automated insulin titration software is expected to provide additional support to patients, enhancing market prospects.

The market landscape is consolidated, with key players like Abbott, Dexcom, and Medtronic leading the charge in technological innovations and product development. The sensors segment, a critical component of CGM devices, is anticipated to experience robust growth due to advancements in sensor technology, including the development of optical measurement platforms. These innovations aim to improve the accuracy and user-friendliness of glucose monitoring systems. The National Service Framework and the Association of British HealthTech Industries are playing pivotal roles in standardizing and improving diabetes care services, further driving market expansion. As the diabetes population in the UK continues to grow, the demand for effective and efficient glucose monitoring solutions is expected to rise, offering substantial opportunities for market players.

Explore More

United Kingdom Continuous Glucose Monitoring Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Component

      1. 2.1.1 Sensors

      2. 2.1.2 Durables

United Kingdom Continuous Glucose Monitoring Market Size FAQs

The United Kingdom Continuous Glucose Monitoring Market is projected to register a CAGR of 15.90% during the forecast period (2024-2029)

Abbott, Medtronics, Dexcom, GlySens and Ascensia are the major companies operating in the United Kingdom Continuous Glucose Monitoring Market.

United Kingdom Continuous Glucose Monitoring Market Report Snapshots

United Kingdom Continuous Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)